Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
86.3M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
45.5M
-
Shares change
-
+12.5M
-
Total reported value, excl. options
-
$353M
-
Value change
-
+$99.1M
-
Put/Call ratio
-
2.93
-
Number of buys
-
55
-
Number of sells
-
-38
-
Price
-
$7.76
Significant Holders of Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) as of Q2 2023
106 filings reported holding ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share as of Q2 2023.
Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45.5M shares
of 86.3M outstanding shares and own 52.76% of the company stock.
Largest 10 shareholders include Nextech Invest Ltd. (4.29M shares), FMR LLC (3.73M shares), Column Group LLC (3.57M shares), EcoR1 Capital, LLC (3.42M shares), ALKEON CAPITAL MANAGEMENT LLC (2.98M shares), Prosight Management, LP (2.76M shares), BlackRock Inc. (2.58M shares), VR Adviser, LLC (2.14M shares), Frazier Life Sciences Management, L.P. (2.14M shares), and VANGUARD GROUP INC (1.8M shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.